Indoco Remedies

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE873D01024
  • NSEID: INDOCO
  • BSEID: 532612
INR
231.80
-1.55 (-0.66%)
BSENSE

Nov 20

BSE+NSE Vol: 1.62 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 601817,
    "name": "Indoco Remedies",
    "stock_name": "Indoco Remedies",
    "full_name": "Indoco Remedies Ltd",
    "name_url": "stocks-analysis/indoco-remedies",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "231.80",
    "chg": -1.55,
    "chgp": "-0.66%",
    "dir": -1,
    "prev_price": "233.35",
    "mcapval": "2,138.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532612,
    "symbol": "INDOCO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE873D01024",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "1.62 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/indoco-remedies-601817-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Indoco Remedies Gains 1.53%: Key Intraday Surge and Mixed Technical Signals Shape Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/indoco-remedies-gains-153-key-intraday-surge-and-mixed-technical-signals-shape-week-4270735",
        "imagepath": "",
        "date": "2026-11-21 17:01:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Technical momentum shifts amid mixed signals</p>\n                    <p><strong>18 Nov:</strong> Intraday high with 11.87% surge</p>\n                    <p><strong>20 Nov:</strong> Week closes at Rs.231.80 (+1.53%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.226.90</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.231.80</div><div class=\"stat-change positive\">+1.53%</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week High</div><div..."
      },
      {
        "title": "Indoco Remedies Ltd Surges 11.87% to Day's High of Rs 250.3 — Outperforms Sector by 11.37 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/indoco-remedies-ltd-hits-intraday-high-with-1187-surge-on-18-nov-2026-4266508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/IndocoRemediesL_priceRelatedfactors_4266508.png",
        "date": "2026-11-18 09:31:37",
        "description": "The Sensex declined 0.33% on 18 Nov 2026, while Indoco Remedies Ltd surged 11.87%, marking a remarkable 11.37-percentage-point outperformance over its Pharmaceuticals &amp; Biotechnology sector. This sharp single-session gain rewrites the short-term narrative for the stock, which had been under pressure in recent weeks."
      },
      {
        "title": "Indoco Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/indoco-remedies-ltd-technical-momentum-shifts-amid-mixed-market-signals-4263034",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/IndocoRemediesL_technicaldot_4263034.png",
        "date": "2026-11-16 08:02:17",
        "description": "Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a modest day change of 0.02% and a current price of ₹228.30, the stock’s technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes."
      },
      {
        "title": "Indoco Remedies Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/indoco-remedies-ltd-is-rated-sell-4257886",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/IndocoRemediesL_mojoScore_4257886.png",
        "date": "2026-11-11 10:10:52",
        "description": "Indoco Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Indoco Remedies Declines 8.34%: Mixed Technical Signals and Margin Pressures Shape the Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/indoco-remedies-declines-834-mixed-technical-signals-and-margin-pressures-shape-the-week-4246014",
        "imagepath": "",
        "date": "2026-10-31 17:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Stock opens at ₹227.30 but drops 3.30% to ₹219.80 amid technical momentum shift</p>\n                    <p><strong>27 Oct:</strong> Slight recovery to ₹220.65 despite broader market gains</p>\n                    <p><strong>28 Oct:</strong> Quarterly results reveal flat performance with margin pressures</p>\n                    <p><strong>29 Oct:</strong> Technical momentum shifts again as stock falls to ₹214.05</p>\n                    <p><strong>30 Oct:</strong> Week closes at ₹208.35, down 0.67% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class..."
      },
      {
        "title": "Indoco Remedies Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/indoco-remedies-ltd-is-rated-sell-4245396",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/IndocoRemediesL_mojoScore_4245396.png",
        "date": "2026-10-31 10:10:24",
        "description": "Indoco Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 October 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Indoco Remedies Ltd Faces Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/indoco-remedies-ltd-faces-technical-momentum-shift-amid-mixed-market-signals-4242737",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/IndocoRemediesL_technicaldot_4242737.png",
        "date": "2026-10-29 08:01:39",
        "description": "Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and bullish signals across multiple timeframes. The stock’s recent downgrade from a Strong Sell to a Sell rating by MarketsMojo, alongside a 2.99% decline in daily price, underscores the evolving market sentiment and technical landscape investors must carefully analyse."
      },
      {
        "title": "Indoco Remedies Ltd Reports Flat Quarterly Performance Amid Margin Pressures",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/indoco-remedies-ltd-reports-flat-quarterly-performance-amid-margin-pressures-4241297",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/IndocoRemediesL_fintrenddot_4241297.png",
        "date": "2026-10-28 08:00:12",
        "description": "Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended September 2026, signalling a pause in its recent downward trend. Despite achieving its highest quarterly net sales to date, the company faces margin pressures due to rising interest costs, prompting a cautious outlook from analysts."
      },
      {
        "title": "Indoco Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/indoco-remedies-ltd-technical-momentum-shifts-amid-mixed-market-signals-4240018",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/IndocoRemediesL_technicaldot_4240018.png",
        "date": "2026-10-27 08:03:35",
        "description": "Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade to Sell from Strong Sell, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This article analyses these technical parameters in detail, providing investors with a comprehensive view of the stock’s current market positioning and outlook."
      }
    ],
    "total": 106,
    "sid": "601817",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/indoco-remedies-601817"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "18-Nov-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Suresh G Kare & Aruna Kare",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "13-Nov-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditi M Panandikar & Others",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "09-Nov-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Suresh G Kare",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has declared <strong>10%</strong> dividend, ex-date: 10 Sep 26",
          "dt": "2026-09-10",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has announced <strong>2:10</strong> stock split, ex-date: 17 May 12",
          "dt": "2012-05-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 17 May 12",
          "dt": "2012-05-17",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

18-Nov-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Suresh G Kare & Aruna Kare

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

13-Nov-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditi M Panandikar & Others

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

09-Nov-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Suresh G Kare

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Indoco Remedies Ltd has declared 10% dividend, ex-date: 10 Sep 26

stock-summary
SPLITS

Indoco Remedies Ltd has announced 2:10 stock split, ex-date: 17 May 12

stock-summary
BONUS

Indoco Remedies Ltd has announced 1:2 bonus issue, ex-date: 17 May 12

stock-summary
RIGHTS

No Rights history available